RMEI Medical Education, LLC

Experience the future of gastroenterology at the RMEI Medical Education booth! We present a groundbreaking Clinical Decision Support Tool (CDST) designed to transform inflammatory bowel disease (IBD) management.  

RMEI understands the challenges gastroenterologists face in providing personalized treatment for patients with IBD. That is where IBDforCDST.com comes in. The U.S. Health Outcomes Consortium – in partnership with RMEI and supported by independent medical education grants from Takeda – developed the IBD CDST to address the need for a validated, drug-specific, user-friendly, prediction tool.  

This free tool, endorsed by the American Gastroenterological Association and hosted by ArcheMedX, can be accessed on any internet-connected device and allows clinicians to assess risk and optimize treatment selection in real time, so they can confidently make well-informed decisions and optimize treatment plans.  

Our user-friendly, innovative platform enables you to seamlessly input basic patient information to predict individual treatment response and tailor your treatment plan accordingly. Powered by cutting-edge AI algorithms that leverage patient data, biomarkers, and medical history, the CDST generates evidence-based insights and treatment recommendations for clinicians.  

We invite you to witness firsthand the impact of AI-driven insights on IBD care. Engage with our team of experts, see live demonstrations, and discover how our intuitive interface makes integrating AI into your workflow a seamless experience whether you are on the web or your mobile device. Join us in shaping the future of gastroenterology care. Empower yourself and be part of the revolution. Together, let us make a difference in the lives of patients living with IBD.  

See you at booth #1812!